IMPACT OF BONE MARROW FIBROSIS IN MYELOMA PATIENTS UNDERGONE AUTOLOGOUS STEM CELL TRANSPLANTATION

Objective: Autologous hematopoetic stem cell transplantation (aHSCT) after high dose chemotherapy is a standard treatment for multiple myeloma (MM) patients. The successful aHSCT depends on collection of sufficient numbers of hematopoietic progenitor stem cells and sustained engraftment following in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Senem Maral, Murat Albayrak, Berna Afacan Öztürk, Ünsal Han, Merih Reis Aras, Gülten Korkmaz, Simten Dagdas, Aynur Albayrak, Gülsüm Özet
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/8fa8c444a7b34afba6e5cafc7670057e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!